Rhabdomyosarcoma, Embryonal
2 clinical trials · Condition
◉ Watch Rhabdomyosarcoma, Embryonal
| Record | Firm | Date |
|---|---|---|
| Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma (NCT03041701) | National Cancer Institute (NCI) | 2017-07-07 |
Track Rhabdomyosarcoma, Embryonal automatically
Every clearance here is in the API, with alerts when new ones post.